T Stanfield, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Madisonville, KYNPI 1689771396
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $9,884 with a category attached, or 60.7%. Intuitive Surgical accounts for 60.9% of it on its own, with 42 other manufacturers making up the rest. Reporting peaked in 2023 at $6,899 and has fallen 89.9% since, to $699 in 2025.
Across 226 payments — averaging $43.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Johnson & Johnson$594
- Novartis$340
- Amgen$337
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$316
- Endologix LLC$253
- plus $2K from 37 others
What the payments were for
- Food & beverage$3,88439%
- Education$6,00061%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $6,017 |
| Johnson & Johnson(2 entities) | 44 | $594 |
| Novartis | 23 | $340 |
| Amgen | 21 | $337 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $316 |
| Endologix LLC | 2 | $253 |
| Bard Peripheral Vascular, Inc. | 14 | $228 |
| Silk Road Medical, Inc. | 5 | $163 |
| Actelion Pharmaceuticals US, Inc. | 7 | $112 |
| Atricure, Inc. | 5 | $106 |
| AstraZeneca | 6 | $102 |
| Sanofi-aventis U.S. LLC | 5 | $98 |
| Angiodynamics, Inc. | 4 | $98 |
| Inari Medical, Inc. | 4 | $87 |
| Boston Scientific | 5 | $76 |
| Abbott | 5 | $73 |
| Amarin Pharma, Inc. | 5 | $71 |
| Surmodics, Inc. | 5 | $68 |
| Pfizer | 5 | $66 |
| Merck | 4 | $63 |
| Boehringer Ingelheim | 4 | $63 |
| Baxter Healthcare | 3 | $54 |
| Medtronic(2 entities) | 3 | $44 |
| Siemens Medical Solutions USA, Inc. | 2 | $44 |
| United Therapeutics Corporation | 2 | $37 |
| Bolton Medical Inc | 2 | $36 |
| GSK | 2 | $35 |
| KCI USA, Inc. | 1 | $30 |
| Kerecis Limited | 1 | $28 |
| Sanofi | 1 | $23 |
| Smith+Nephew | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Grifols USA, LLC | 1 | $18 |
| Kls-martin L.p. | 2 | $18 |
| Solventum Corporation | 1 | $17 |
| Stryker | 1 | $16 |
| Reflow Medical Inc | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Verona Pharma, Inc. | 1 | $14 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,000
How this compares
$9,884 in reported general payments places this provider in the 65th percentile of 98 thoracic surgery (cardiothoracic vascular surgery) providers in Kentucky.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 22 | $17,370 |
| ClopidogrelClopidogrel Bisulfate | 88 | $733 |
| Cilostazol | 41 | $598 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $147 |
| Mupirocin | 24 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $594 | $17,37022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 98 thoracic surgery (cardiothoracic vascular surgery) providers in Kentucky.
Other thoracic surgery (cardiothoracic vascular surgery) in Madisonville
- David LaddenMadisonville$23K
- Steven PetersonLouisville$283K
- Mario Castillo-SangEdgewood$163K
- Edward CantuLexington$74K
- Mansi Shah-JadejaLexington$45K
- Anthony MozerOwensboro$43K
- Mark SlaughterLouisville$39K
- Michael KastenEdgewood$32K
- Alberto de HoyosLexington$32K
- Juan Penaranda-CanalEdgewood$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.